PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT

NCT04669210 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Graft-versus-host-disease
Stem Cell Transplant Complications
Acute Myeloid Leukemia
Acute Lymphoid Leukemia

Interventions

DRUG: Ruxolitinib
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil

Sponsor

St. Petersburg State Pavlov Medical University